7th Annual MarketsandMarkets

Real-World Evidence and Life Sciences Analytics Conference

17th - 18th October 2024

Boston, USA

Evidence Unveiled: Bridging Data Analytics and Evidence for Better Patient Outcomes

We are thrilled to welcome you to the 7th Annual Real-World Evidence and Life Science Analytics Conference at Boston 2024, a premier gathering of thought leaders, industry experts, and innovators at the forefront of revolutionizing healthcare through data-driven insights. Set against the backdrop of advancements in real-world evidence, this conference promises an enriching experience for professionals in life sciences, healthcare, and analytics.

The 7th Annual Real-World Evidence and Life Science Analytics Conference is not just an event; it's an opportunity to be part of the conversation shaping the future of healthcare. Join us for an inspiring and collaborative experience as we explore ways to bridge insights to impact in the dynamic world of real-world evidence.

WHAT TO EXPECT

  • Gain insights into regulatory perspectives on data quality and standards, Integration of RWE into Clinical Trials
  • Explore the strategic utilization of Real-World Evidence (RWE) to enhance market access. 
  • Regulatory Landscape for Medical Devices, Post-Market Surveillance and Safety Monitoring
  • Uncover the expanded realm of RWE's influence on digital health, Patient-Centric Approaches in Device Research
  • Examine the synergy between Real-World Data and Advanced Analytics, Economic impact evaluations using real-world evidence. 
  • Epidemiological Insights using Real World Evidence

  • Latest insights and updates on trends
  • Networking opportunities
  • Professional Development
  • Interdisciplinary Learning
  • Insights into current regulatory perspectives
  • Access to Thought Leaders
  • Showcasing innovative technologies

From pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-

  • Real-World Evidence
  • Real-World Data
  • Data Analytics
  • Health Economics & Outcomes Research- HEOR
  • Market Access/Value Access
  • Policy
  • Clinical Development & research
  • Clinical trial
  • Centre for Observational and Real-World Evidence  
  • Epidemiology
  • Oncology-RWE
  • Pricing and Reimbursement
  • Medical Affairs
  • Pharmacovigilance
  • Life Science Analytics
  • Big data
  • Data Science
  • Bio-Statistics
  • Consumer Healthcare

Others

Payers, Regulators, Research Institutes, and Innovation Centre

CONFERENCE AGENDA

Evidence Synergy: Bridging Outcomes, Access, and Analytics for Real-World Impact

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks by the Chairperson

08:55 - 09:00

Integration of RWE into Clinical Trials

Keynote Presentation - Strategies for incorporating real-world data into traditional clinical trial designs

09:00 - 09:30

Health system adoption of evidence from clinical trials and real-world studies

09:30 - 10:00

Slot Reserved for Sponsors (Gold/Platinum) - Forian

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meeting

10:30 - 11:10

Patient-Centered Outcomes Research

Using Patient-Generated Health Data for more Nuanced Clinical Outcomes for Medical Product Development

Nancy Dreyer

Nancy Dreyer, Adjunct Professor of Epidemiology, University of North Carolina, Chapel Hill

11:10 - 11:40

Slot Reserved for Sponsors (Gold/Silver) – Prognos health

11:40 - 12:10

Methods for incorporating patient perspectives into research. Measuring what you want to manage: new approaches to measure patient diversity in RWE.

Adrian Kielhorn

Adrian Kielhorn, Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc

12:10 - 12:40

Slot Reserved for Sponsors (Silver) – OM1/Komodo

12:40 - 13:10

Lunch and Poster Presentation | One-to-One Networking

13:10 - 14:10

Health Economics and Market Access

Economic impact evaluations using real-world evidence.

14:10 - 14:40

Slot Reserved for Sponsors (Bronze)

14:40 - 15:15

Demonstrating value and reimbursement strategies.

15:15 - 15:55

Evening Refreshments | One-to-One Networking

15:55 - 16:35

AI and ML Applications in Life Sciences RWE

Slot Reserved for Sponsors

16:35 - 17:05

Applications of artificial intelligence and machine learning in analyzing and deriving insights.

17:05 - 17:35

Slot Reserved for Sponsors

17:35 - 18:05

Predictive analytics for patient recruitment, enrollment, and retention.

18:05 - 18:35

Closing remarks by the Chairperson

18:35 - 18:35

End of Conference | Drinks and Reception

18:35 - 18:35

InnovateHealth: Precision Solutions in Evidence, Medicine, and Epidemiology

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks by the Chairperson

08:55 - 09:00

Healthcare Innovation and Technology

Blockchain and other technologies for data integrity and transparency.

09:00 - 09:30

Impact of technological advancements on patient outcomes

09:30 - 10:00

Slot Reserved for Sponsors (Gold/Platinum)

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meeting

10:30 - 11:10

Precision Medicine and Personalized Healthcare

Genomic data integration in patient outcomes research.

11:10 - 11:40

Slot Reserved for Sponsors (Silver)

11:40 - 12:10

Tailoring treatments based on real-world evidence.

12:10 - 12:40

Slot Reserved for Sponsors

12:40 - 13:10

Lunch and Poster Presentation | One-to-One Networking

13:10 - 14:10

Epidemiological Insights from Real-World Evidence

Large-scale epidemiological studies using real-world evidence.

14:10 - 14:40

Population-level insights for public health decision-making.

14:40 - 15:10

Closing remarks by the Chairperson

15:10 - 15:10

----End of Conference---

15:10 - 15:10

SPEAKERS

Megan Sutton

Megan Sutton

Senior Medical Director, Clinical Development and Real-world Evidence, Lexeo Therapeutics

Adrian Kielhorn

Adrian Kielhorn

Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc

Amit Kulkarni

Amit Kulkarni

Head of Health Economic Modeling and Decision Sciences, Otsuka Pharmaceutical Companies

Nancy Dreyer

Nancy Dreyer

Adjunct Professor of Epidemiology, University of North Carolina, Chapel Hill

ENQUIRE NOW

SPONSORS

LOCATION

Venue

Boston, USA

PAST EVENT GALLERY